Holocene Advisors
AZN icon

Holocene Advisors’s AstraZeneca AZN Stock Holding History

Holocene Advisors’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$461M Sell
2,429,349
-233,538
-9% -$43.9M 1.04% 13
2026
Q1 		$525M Buy
2,662,887
+496,825
+23% +$95.8M 1.27% 10
2025
Q4 		$398M Sell
2,166,062
-898,535
-29% -$158M 0.84% 19
2025
Q3 		$470M Buy
3,064,597
+903,782
+42% +$137M 1.07% 9
2025
Q2 		$302M Sell
2,160,815
-62,376
-3% -$8.74M 0.74% 26
2025
Q1 		$327M Buy
2,223,191
+72,990
+3% +$10.6M 0.95% 26
2024
Q4 		$282M Buy
+2,150,201
New +$301M 0.9% 18
2024
Q3 		– Sell
-1,264,512
Closed -$197M – 716
2024
Q2 		$197M Sell
1,264,512
-1,472,174
-54% -$222M 0.82% 29
2024
Q1 		$371M Buy
2,736,686
+647,639
+31% +$85.8M 1.36% 5
2023
Q4 		$281M Buy
2,089,047
+851,241
+69% +$111M 1.1% 10
2023
Q3 		$168M Buy
1,237,806
+387,361
+46% +$52.9M 0.73% 36
2023
Q2 		$122M Sell
850,445
-5,303
-0.6% -$780K 0.52% 62
2023
Q1 		$119M Sell
855,748
-344,584
-29% -$46.4M 0.58% 53
2022
Q4 		$163M Buy
1,200,332
+150,816
+14% +$18.9M 0.99% 19
2022
Q3 		$115M Buy
1,049,516
+178,013
+20% +$22.6M 0.74% 45
2022
Q2 		$115M Buy
+871,503
New +$114M 0.7% 43
2021
Q4 		– Sell
-574,697
Closed -$69M – 853
2021
Q3 		$69M Buy
574,697
+139,700
+32% +$16.3M 0.38% 87
2021
Q2 		$52.1M Sell
434,997
-149,594
-26% -$16.4M 0.29% 117
2021
Q1 		$58.1M Buy
+584,591
New +$58.8M 0.36% 88
2020
Q3 		– Sell
-158,126
Closed -$16.7M – 673
2020
Q2 		$16.7M Buy
+158,126
New +$16.3M 0.15% 164
2020
Q1 		– Sell
-82,638
Closed -$8.24M – 671
2019
Q4 		$8.24M Sell
82,638
-542,483
-87% -$51.1M 0.07% 163
2019
Q3 		$55.7M Buy
625,121
+368,438
+144% +$31.9M 0.57% 57
2019
Q2 		$21.2M Buy
+256,683
New +$20.1M 0.27% 111

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Holocene Advisors's AZN Position: Q2 2026 in Review

Holocene Advisors reduced its AstraZeneca (AZN) stake by 8.8% in Q2 2026, selling an estimated $43.9M and leaving 2,429,349 shares worth $461M. The position accounts for 1.04% of the portfolio, ranked #13.

Holocene Advisors first reported a position in AZN in Q2 2019 and has held it in 23 quarters since. The position peaked at $525M in Q1 2026. 1,498 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Holocene Advisors held 2,429,349 shares of AstraZeneca worth $461M as of Q2 2026.
  • Holocene Advisors sold 233,538 AstraZeneca shares in Q2 2026, an estimated $43.9M.
  • AstraZeneca made up 1.04% of Holocene Advisors's portfolio in Q2 2026, its #13 holding.
  • Holocene Advisors first reported a position in AstraZeneca in Q2 2019 and has held it in 23 quarters since.
  • Holocene Advisors's AstraZeneca position peaked at $525M in Q1 2026.
  • 1,498 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Holocene Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.